Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Treatment
Volume 2011, Article ID 239501, 9 pages
http://dx.doi.org/10.1155/2011/239501
Clinical Study

A Phase IIIb, Multicentre, Randomised, Parallel-Group, Placebo-Controlled, Double-Blind Study to Investigate the Efficacy and Safety of OROS Hydromorphone in Subjects with Moderate-to-Severe Chronic Pain Induced by Osteoarthritis of the Hip or the Knee

1Orthos Paidion, 83263 Bratislava, Slovakia
2Dianthus Medical Limited, London SW19 2RL, UK
3EMEA Medical Affairs, Analgesia, Janssen-Cilag, Quarryvale, Co Dublin, Ireland
4Medical Affairs, Janssen-Cilag Europe, 6341 Baar, Switzerland
5Global Medical Affairs, GMAL Mature Products, Johnson & Johnson Pharmaceutical Services, LLC, 6341 Baar, Switzerland

Received 8 December 2010; Accepted 19 April 2011

Academic Editor: Anna Maria Aloisi

Copyright © 2011 Jozef Vojtaššák et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jozef Vojtaššák, Jozef Vojtaššák, Adam Jacobs, Leonie Rynn, Sandra Waechter, and Ute Richarz, “A Phase IIIb, Multicentre, Randomised, Parallel-Group, Placebo-Controlled, Double-Blind Study to Investigate the Efficacy and Safety of OROS Hydromorphone in Subjects with Moderate-to-Severe Chronic Pain Induced by Osteoarthritis of the Hip or the Knee,” Pain Research and Treatment, vol. 2011, Article ID 239501, 9 pages, 2011. https://doi.org/10.1155/2011/239501.